MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Quotient Limited ROE 2011-2026 | QTNT
ROE Jährlich Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 312.05 | 1859.47 | -6148.54 | 562.76 | 353.12 | -72.51 | 3656.9 | 32.23 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3656.9 | -6148.54 | 69.44 |
ROE Vierteljährlich Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 152.07 | 181.38 | 243.77 | 240.86 | 309.43 | -1138.02 | -1642.41 | -1775.74 | -1760.06 | -500.5 | -264.59 | -162.67 | -135.68 | -89.97 | -44.25 | 83.94 | -558.85 | -983.93 | -745.0 | -851.72 | -238.46 | 906.37 | 537.84 | 256.59 | 219.15 | -431.54 | -447.66 | -115.17 | 417.88 | 988.37 | 668.7 | -100.1 | -100.1 | -633.16 | -61.29 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 988.37 | -1775.74 | -216.41 |
ROE anderer Aktien in der Diagnostik & Forschung
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M |  USA |
 |
Agilent Technologies
A
|
22.45 | $ 118.25 | -1.27 % | $ 35.9 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 22.5 | 9.44 % | $ 242 M |  China |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 22.42 | 27.6 % | $ 1.19 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 1.46 | 2.82 % | $ 1.94 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 24.56 | -0.24 % | $ 682 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 176.94 | -2.0 % | $ 8.77 B | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 515.65 | -0.56 % | $ 14.9 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Danaher Corporation
DHR
|
6.88 | $ 193.78 | -2.18 % | $ 138 B | USA |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 2.2 | - | $ 9.73 M | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 8.16 | -5.99 % | $ 1.05 B | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.24 | -1.91 % | $ 2 B | USA |
 |
Illumina
ILMN
|
-51.54 | $ 132.72 | 0.35 % | $ 21.1 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 16.13 | -0.25 % | $ 488 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 28.63 | -1.58 % | $ 20 B |  Niderland |
 |
Guardant Health
GH
|
419.18 | $ 85.7 | 0.99 % | $ 10.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 2.83 | -3.41 % | $ 91.8 K | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.2 | 4.27 % | $ 5.05 M | USA |
 |
Senseonics Holdings
SENS
|
-113.21 | $ 6.77 | -1.88 % | $ 282 M | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 115.58 | -0.79 % | $ 9.53 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 266.36 | -0.14 % | $ 22.2 B | USA |
 |
Soleno Therapeutics
SLNO
|
4.64 | $ 52.57 | - | $ 2.67 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Celcuity
CELC
|
-176.06 | $ 125.25 | 1.44 % | $ 5.86 B | USA |
 |
Neuronetics
STIM
|
-174.27 | $ 1.4 | 0.72 % | $ 92.3 M | USA |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 5.0 | -3.66 % | $ 463 M | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 83.92 | -0.02 % | $ 5.66 B | USA |
 |
Thermo Fisher Scientific
TMO
|
12.55 | $ 516.0 | -2.95 % | $ 195 B | USA |
 |
Trinity Biotech plc
TRIB
|
287.88 | $ 0.7 | -0.54 % | $ 61.9 M | Irlanda |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 191.46 | 0.02 % | $ 21.3 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-310.93 | $ 5.17 | 0.58 % | $ 4.07 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 56.23 | -2.41 % | $ 3.36 B | USA |